Login / Signup

Successful management of a high-risk acute myeloid leukemia patient with severe coronary heart disease by venetoclax plus azacytidine and coronary artery bypass grafting.

Wen-Jing YuYing WuJian LiuYu ChenRui-Qin HouXiao-Jun HuangHao Jiang
Published in: Journal of translational internal medicine (2024)
Keyphrases